DAAM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.663020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.106240E-01
Normal-vs-Stage2
9.980200E-02
Normal-vs-Stage3
1.725390E-01
Normal-vs-Stage4
7.447400E-01
Stage1-vs-Stage2
6.386800E-01
Stage1-vs-Stage3
3.971600E-01
Stage1-vs-Stage4
2.954800E-01
Stage2-vs-Stage3
1.836090E-02
Stage2-vs-Stage4
2.464200E-01
Stage3-vs-Stage4
2.377600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.245420E-01
Normal-vs-AfricanAmerican
2.862800E-01
Normal-vs-Asian
1.589390E-01
Caucasian-vs-AfricanAmerican
9.351600E-01
Caucasian-vs-Asian
5.825600E-01
AfricanAmerican-vs-Asian
7.066800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.761590E-01
Normal-vs-Female
1.753840E-01
Male-vs-Female
9.825000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.251000E-01
Normal-vs-Age(41-60Yrs)
4.463800E-01
Normal-vs-Age(61-80Yrs)
1.056610E-01
Normal-vs-Age(81-100Yrs)
2.740000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.464600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.680400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.564000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.255500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.065530E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.852000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.839600E-02
Normal-vs-Daily Drinker
5.582000E-02
Normal-vs-Weekly Drinker
6.604200E-03
Normal-vs-Occasional Drinker
7.545600E-01
Normal-vs-Social Drinker
6.237600E-01
Non Drinker-vs-Daily Drinker
8.128000E-01
Non Drinker-vs-Weekly Drinker
3.496600E-01
Non Drinker-vs-Occasional Drinker
3.895900E-02
Non Drinker-vs-Social Drinker
1.686160E-01
Daily Drinker-vs-Weekly Drinker
2.873400E-01
Daily Drinker-vs-Occasional Drinker
5.865700E-02
Daily Drinker-vs-Social Drinker
2.160000E-01
Weekly Drinker-vs-Occasional Drinker
1.158040E-02
Weekly Drinker-vs-Social Drinker
7.061900E-02
Occasional Drinker-vs-Social Drinker
7.091800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.739430E-01
Normal-vs-Grade 2
1.222770E-01
Normal-vs-Grade 3
1.249620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.352800E-01
Grade 1-vs-Grade 3
6.427800E-01
Grade 1-vs-Grade 4
1.739430E-01
Grade 2-vs-Grade 3
2.902000E-01
Grade 2-vs-Grade 4
1.222770E-01
Grade 3-vs-Grade 4
1.249620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.366200E-02
Normal-vs-NonDiabetic
1.679580E-01
Diabetic-vs-NonDiabetic
7.835600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.460300E-02
Normal-vs-NoPancreatitis
1.743030E-01
Pancreatitis-vs-NoPancreatitis
2.097600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.991200E-01
Normal-vs-N1
1.114370E-01
N0-vs-N1
7.420200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.547600E-01
Normal-vs-TP53-NonMutant
2.615600E-01
TP53-Mutant-vs-TP53-NonMutant
5.338400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
